Precision BioSciences Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 10, 2022, details the results of the annual meeting of stockholders held by Precision BioSciences, Inc. (DTIL) on that date. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 46,596,353 shares were present at the meeting, representing approximately 76.34% of the outstanding common stock as of the March 15, 2022 record date. The following proposals were approved:
- Item 1: Election of Directors
- Kevin J. Buehler: Elected with 22,084,103 votes FOR, 13,223,253 votes WITHHELD, and 11,288,997 Broker Non-Votes.
- Shari Lisa Piré: Elected with 34,514,837 votes FOR, 792,519 votes WITHHELD, and 11,288,997 Broker Non-Votes.
- Item 2: Ratification of Auditors
- Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2022.
- Votes: 46,495,413 FOR, 59,702 AGAINST, 41,238 ABSTAINED, and 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the official election of Kevin J. Buehler and Shari Lisa Piré as Class III directors serving until 2025.
- Confirm the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2022.
- Note the significant number of broker non-votes (11,288,997) recorded for the director elections.
- Review the Definitive Proxy Statement filed on March 29, 2022, for detailed background on the proposals.